With specialist IP providers offering post-M&A services at lower cost than traditional law firms, have clients been overspending in the past? Melissa Pillote on behalf of Dennemeyer reports.
Latest asia news
Japan-based Sawai Pharmaceutical has agreed to buy the generic drugs business of Upsher-Smith Laboratories for nearly $1.1 billion.
- Sun Pharma acquires Biosintez 24-11-2016